A paucity of substantive data from clinical drug trials is available specifically evaluating the
effects of therapy for hypercholesterolemia in African-Americans, even though a substantial …

PURPOSE: To evaluate the efficacy of lovastatin in African Americans (AA) diagnosed with
primary hypercholesterolemia. PATIENTS AND METHODS: Forty-seven AA patients from the …

The randomized, double-blind, placebo-controlled trial described in this report was
undertaken to clarify the dose-response relation of lovastatin therapy to lipid-modifying …

Abstract The Expanded Clinical Evaluation of Lovastatin study, a randomized, double-blind,
placebo-and diet-controlled multicenter trial, evaluated the efficacy and tolerability of …

This study reports the results of a 6-month, open-label multicenter study of the efficacy and
tolerability of lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase …

A randomized, controlled, double-blind trial in 672 hypercholesterolemic patients evaluated
the efficacy and safety profile of lovastatin and pravastatin across their usually …

This randomized, double-blind, multicenter, diet-and-placebo-controlled study was designed
to clarify the dose-response relationship of lovastatin therapy to lipid-modifying efficacy and …

In the multicenter, double-blind EXCEL (Expanded Clinical Evaluation of Lovastatin) study
the efficacy of lovastatin in modifying plasma lipids and lipoproteins in 8,245 participants …

The lipid-modifying effects of statin therapy in hypercholesterolemic African-Americans have
not been well characterized. This study compared the efficacy and safety of rosuvastatin and …

In the Expanded Clinical Evaluation of Lovastatin (EXCEL) Study, a multicenter, double-
blind, diet-and placebo-controlled trial, we evaluated the efficacy and safety of lovastatin in …